Phase I, Placebo-Controlled, Blinded Pilot Study of Ipratropium in Children Admitted to the ICU With Status Asthmaticus

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
This study is a Phase I study to investigate the addition of inhaled Ipratropium bromide to standard therapy in the treatment of severe asthma attacks in children admitted to the Pediatric Intensive Care Unit. Half of the subjects will receive inhaled Ipratropium, and half will receive an inhaled placebo.
Epistemonikos ID: 7095b361cf7e1f87cb1e51c047895cc4a56094a4
First added on: May 17, 2024